Furthermore, a deeper clustering of immune cells with the help of novel technology, such as single-cell RNA sequencing [40], using more precise markers, for example, to identify Foxp3+ Treg cells from CD4+ T cells, and in different tumor regions, might provide further insight into the distinct prognostic role of various immune cell subsets in the tumor microenvironment. Here, CD4 is linked to neoplasm.